Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals

Open Access

Peer-reviewed

Research Article

Annette Pachnio,

Affiliation School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
⨯
Jusnara Begum,

Affiliation School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
⨯
Ashini Fox,

Affiliation Department of Genito Urinary Medicine, Nottingham University Hospitals Trust, Nottingham, United Kingdom
⨯
Paul Moss

* E-mail: p.moss@bham.ac.uk

Affiliation School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
⨯

Reader Comments (0)

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Human cytomegalovirus
Is the Subject Area "Human cytomegalovirus" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cytomegalovirus infection
Is the Subject Area "Cytomegalovirus infection" applicable to this article?

Thanks for your feedback.
Immune suppression
Is the Subject Area "Immune suppression" applicable to this article?

Thanks for your feedback.